Skip to content

Treatment with Ayurveda oil application in form of shiropichu to improve sleep quality in breast cancer patients

A randomized controlled clinical trial to evaluate the effect of Shiropichu (An ayurveda procedure) with koumudi oil in improving sleep quality in breast cancer patients with complaints of insomnia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025586
Enrollment
60
Registered
2020-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Kaumodi Oil Shiropichu with Rasayana therapy: Kaumodi oil -10 ml medicated Shiropichu for local application on Anterior fontanelle for minimum 6 hours for 30 days + Oral Cap Tejonidhi

Sponsors

Rasayu Cancer Clinic
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Breast Cancer survivors who have been treated for malignancy 2 Breast cancer patients who is on active treatment for malignancy 2 Breast cancer patients having complaints of Insomnia (A global score of > 5 in The Pittsburgh Sleep Quality Index (PSQI)) 3 Participant who feels that the insomnia was caused/aggravated by cancer or cancer treatment

Exclusion criteria

Exclusion criteria: 1 Patients with malignant lesions in Brain 2 Patients who have comorbid neurological disease 3 Patients taking any other conventional or alternative treatment for Anxiety, Depression and/or Insomnia. 4 Having a medical condition other than cancer that causes insomnia 5 Experiencing a psychiatric disturbance (major depression, psychosis) 6 Experiencing substance abuse 7 Patients taking Morphine treatment

Design outcomes

Primary

MeasureTime frame
Changes in sleep quality index as assesed by Pittsburg sleep quality indexTimepoint: Baseline and Day 30

Secondary

MeasureTime frame
To evaluate safety and tolerability and adherence of patients to Kaumodi oil SiropichuTimepoint: Baseline and Day 30

Countries

India

Contacts

Public ContactDr Yogesh Bendale

Rasayu Cancer Clinic

dr.bendale@gmail.com02024537149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026